Skip to main content

Laboratory Co. of America Stock Forecast, Price & News

$275.91
-0.66 (-0.24 %)
(As of 05/14/2021 02:24 PM ET)
Add
Compare
Today's Range
$275.71
$279.88
50-Day Range
$248.48
$278.14
52-Week Range
$155.19
$280.69
Volume6,681 shs
Average Volume691,018 shs
Market Capitalization$26.96 billion
P/E Ratio32.12
Dividend YieldN/A
Beta1.09
30 days | 90 days | 365 days | Advanced Chart
Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Co. of America logo

About Laboratory Co. of America

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127
Employees65,160
Year Founded1976

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$24.37 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap$26.96 billion
Next Earnings Date7/27/2021 (Estimated)
OptionableOptionable

Social Links


MarketRank

Overall MarketRank

1.26 out of 5 stars

Medical Sector

896th out of 2,039 stocks

Medical Laboratories Industry

14th out of 38 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

Is Laboratory Co. of America a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last twelve months. There are currently 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Laboratory Co. of America stock.
View analyst ratings for Laboratory Co. of America
or view top-rated stocks.

What stocks does MarketBeat like better than Laboratory Co. of America?

Wall Street analysts have given Laboratory Co. of America a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Laboratory Co. of America wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Laboratory Co. of America
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) posted its quarterly earnings data on Wednesday, April, 28th. The medical research company reported $8.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.32 by $1.47. The medical research company earned $4.16 billion during the quarter, compared to analysts' expectations of $3.88 billion. Laboratory Co. of America had a net margin of 6.79% and a trailing twelve-month return on equity of 21.05%.
View Laboratory Co. of America's earnings history
.

How has Laboratory Co. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LH shares have increased by 73.7% and is now trading at $276.14.
View which stocks have been most impacted by COVID-19
.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America issued an update on its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of 20.000-24.000 for the period, compared to the Thomson Reuters consensus estimate of $21.320. The company issued revenue guidance of $14.26 billion-$14.89 billion, compared to the consensus revenue estimate of $14.25 billion.

What price target have analysts set for LH?

13 Wall Street analysts have issued 1 year target prices for Laboratory Co. of America's shares. Their forecasts range from $217.00 to $320.00. On average, they expect Laboratory Co. of America's stock price to reach $266.14 in the next twelve months. This suggests that the stock has a possible downside of 3.6%.
View analysts' price targets for Laboratory Co. of America
or view top-rated stocks among Wall Street analysts.

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Mr. Adam H. Schechter, Pres, CEO & Chairman (Age 56, Pay $1.79M)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 60, Pay $1.46M)
  • Mr. Lance V. Berberian, Exec. VP and Chief Information & Technology Officer (Age 58, Pay $876.62k)
  • Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH, Exec. VP, Pres of Diagnostics & Chief Medical Officer (Age 47, Pay $3.36M)
  • Mr. Mark S. Schroeder, Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain (Age 59, Pay $3.19M)
  • Dr. Michelle Abelson, Laboratory Director of Operations
  • Mr. Peter J. Wilkinson, Sr. VP & Chief Accounting Officer (Age 50) (LinkedIn Profile)
  • Dr. Marcia T. Eisenberg, Chief Scientific Officer & Sr. VP
  • Clarissa Willett, VP of Investor Relations
  • Ms. Sandra D. Van Der Vaart, Exec. VP, Chief Legal Officer, Chief Compliance Officer & Corp. Sec. (Age 61)

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America CEO Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among Laboratory Co. of America's employees.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.27%), Franklin Resources Inc. (1.81%), Geode Capital Management LLC (1.75%), Dimensional Fund Advisors LP (1.43%), JPMorgan Chase & Co. (1.41%) and Alliancebernstein L.P. (1.30%). Company insiders that own Laboratory Co. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson and R Sanders Williams.
View institutional ownership trends for Laboratory Co. of America
.

Which major investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Renaissance Technologies LLC, Sectoral Asset Management Inc, Nicholas Company Inc., AMI Asset Management Corp, Waddell & Reed Financial Inc., Bank of Nova Scotia, and Franklin Resources Inc.. Company insiders that have sold Laboratory Co. of America company stock in the last year include Der Vaart Sandra D Van, Jean-Luc Belingard, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, and R Sanders Williams.
View insider buying and selling activity for Laboratory Co. of America
or view top insider-selling stocks.

Which major investors are buying Laboratory Co. of America stock?

LH stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., M&G Investment Management Ltd., UBS Asset Management Americas Inc., Massachusetts Financial Services Co. MA, Virginia Retirement Systems ET AL, Geode Capital Management LLC, and Allianz Asset Management GmbH.
View insider buying and selling activity for Laboratory Co. of America
or or view top insider-buying stocks.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $276.14.

How much money does Laboratory Co. of America make?

Laboratory Co. of America has a market capitalization of $26.98 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

Laboratory Co. of America employs 65,160 workers across the globe.

When was Laboratory Co. of America founded?

Laboratory Co. of America was founded in 1976.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

Where are Laboratory Co. of America's headquarters?

Laboratory Co. of America is headquartered at 358 South Main Street, BURLINGTON NC, 27215.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.